NEW YORK (GenomeWeb News) – The Research Institute at Nationwide Children's Hospital has been named a certified service provider for Agilent Technologies' array-based comparative genomic hybridization and gene expression assays on the Agilent platform.
Agilent said that the hospital had to complete training and pass a "rigorous series of assessments" including demonstrating proficiency in analyzing Agilent 60-mer oligo microarrays, maintaining sample quality control using the Agilent 2100 Bioanalyzer, and analyzing data using the GeneSpring bioinformatics platform.
"The investigators working with us have been tremendously happy with the data we produce, which has led to rapidly growing demand for our Agilent gene expression and CGH services," Peter White, director of the biomedical genomics core at the Columbus, Ohio-based hospital, said in a statement. "We're committed to producing publication-quality data sets and so obtaining CSP status was the logical next step for us."